Has Robert Fredericks, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,051 in general payments to Robert Fredericks, MD across 448 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Fredericks, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Fredericks, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Fredericks, MD

Endocrinology, Diabetes & Metabolism · Reno, NVNPI 1336156546

Payments from drug & device makers

$10,051in general payments, 2019–2025

Across 448 payments — averaging $22.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

OPKO Pharmaceuticals, LLC$2K
Amgen$990
Corcept Therapeutics$636
AstraZeneca$578
Esperion Therapeutics, Inc.$511
AbbVie$505
plus $5K from 39 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
OPKO Pharmaceuticals, LLC	162	$1,982
Amgen(2 entities)	32	$990
Corcept Therapeutics	19	$636
AstraZeneca(2 entities)	20	$578
Esperion Therapeutics, Inc.	60	$511
AbbVie	10	$505
Johnson & Johnson	7	$493
Ascendis Pharma Endocrinology Inc	10	$481
Lilly USA, LLC	9	$374
Sanofi-aventis U.S. LLC	7	$323
Bayer	12	$315
Lexicon Pharmaceuticals, Inc.	4	$284
Xeris Pharmaceuticals, Inc.	11	$238
Radius Health, Inc.	3	$233
Novartis	8	$194
Regeneron Healthcare Solutions, Inc.	7	$183
Kyowa Kirin, Inc.	5	$175
Abbott	12	$175
Madrigal Pharmaceuticals	3	$170
Soleno Therapeutics, Inc.	2	$163
Ultragenyx Pharmaceutical Inc.	4	$129
Ferring Pharmaceuticals Inc.	5	$114
Takeda Pharmaceuticals U.S.A., Inc.	4	$103
BETA Bionics, Inc.	2	$73
Medtronic	4	$68
Astellas Pharma US Inc	2	$55
Novo Nordisk	2	$52
Recordati_rare_diseases_inc.	2	$52
Shire North American Group Inc	3	$49
Sandoz	1	$35
Almatica Pharma LLC	2	$29
Zealand Pharma US, Inc.	1	$29
Amryt Pharma Holdings Ltd	1	$28
Ionis Pharmaceuticals, Inc.	1	$27
Alvogen Inc	1	$23
Nevro Corp.	1	$23
Renalytix AI, Inc.	1	$22
Therapeuticsmd, Inc.	1	$22
Medicure Pharma Inc.	1	$21
Merck	1	$19
Ipsen Biopharmaceuticals, Inc	1	$16
Biohaven Pharmaceuticals, Inc.	1	$16
Mannkind Corporation	1	$16
Biohaven Pharmaceutical Holding Company Ltd.	1	$14
Antares Pharma, Inc.	1	$14

How this compares

$10,051 in reported general payments places this provider in the 65th percentile of 75 endocrinology, diabetes & metabolism providers in Nevada.

See all endocrinology, diabetes & metabolism providers in Nevada →

Medicare billing

Part B allowed, 2024

$177,543

Medicare patients

334

Services billed

1,443

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Reno

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →